Studies about waning vaccine effectiveness could be a warning for the government

Support us and go ad-free Clinical experts have warned that the effectiveness of a second coronavirus (Covid-19) vaccine against the Delta variant will likely wane after three months. But the Johnson government appears to be ignoring these warnings. And according to one leading clinician, the UK government may simply be making matters worse. Effectiveness waning …
Continue reading Studies about waning vaccine effectiveness could be a warning for the government

Cost benefit analysis: health economic studies

This page is part of a guide to evaluating digital health products. Cost benefit analysis (CBA) is one economic evaluation tool to compare the costs and effects of alternative interventions. CBA measures both costs and effects of interventions in monetary terms. This usually involves placing a monetary value on health benefits. As all effects are …
Continue reading Cost benefit analysis: health economic studies

Cost utility analysis: health economic studies

This page is part of a guide to evaluating digital health products. Cost utility analysis (CUA) is one type of economic evaluation that can help you compare the costs and effects of alternative interventions. CUA measures health effects in terms of both quantity (life years) and quality of life. These are combined into a single …
Continue reading Cost utility analysis: health economic studies

Cost effectiveness analysis: health economic studies

This page is part of a guide to evaluating digital health products. Cost effectiveness analysis (CEA) is one type of economic evaluation that compares the costs and effects of alternative health interventions. CEA focuses on assessing the intervention’s impact on clinical measures, unlike other types of economic evaluation that consider broader effects. CEA measures effects …
Continue reading Cost effectiveness analysis: health economic studies